JPWO2021074399A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021074399A5 JPWO2021074399A5 JP2022521680A JP2022521680A JPWO2021074399A5 JP WO2021074399 A5 JPWO2021074399 A5 JP WO2021074399A5 JP 2022521680 A JP2022521680 A JP 2022521680A JP 2022521680 A JP2022521680 A JP 2022521680A JP WO2021074399 A5 JPWO2021074399 A5 JP WO2021074399A5
- Authority
- JP
- Japan
- Prior art keywords
- product
- highly lipophilic
- weight
- product according
- cannabinoids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025279962A JP2026034780A (ja) | 2019-10-16 | 2025-12-24 | 高親油性生理活性物質の放出制御製剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19203549.1A EP3808336A1 (de) | 2019-10-16 | 2019-10-16 | Kontrolliert freisetzende formulierungen stark lipophiler physiologisch aktiver substanzen |
| EP19203549.1 | 2019-10-16 | ||
| PCT/EP2020/079244 WO2021074399A1 (de) | 2019-10-16 | 2020-10-16 | Kontrolliert freisetzende formulierungen stark lipophiler physiologisch aktiver substanzen |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025279962A Division JP2026034780A (ja) | 2019-10-16 | 2025-12-24 | 高親油性生理活性物質の放出制御製剤 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022553652A JP2022553652A (ja) | 2022-12-26 |
| JP2022553652A5 JP2022553652A5 (https=) | 2023-10-19 |
| JPWO2021074399A5 true JPWO2021074399A5 (https=) | 2023-10-19 |
| JP7850068B2 JP7850068B2 (ja) | 2026-04-22 |
Family
ID=68281165
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022521680A Active JP7850068B2 (ja) | 2019-10-16 | 2020-10-16 | 高親油性生理活性物質の放出制御製剤 |
| JP2025279962A Pending JP2026034780A (ja) | 2019-10-16 | 2025-12-24 | 高親油性生理活性物質の放出制御製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025279962A Pending JP2026034780A (ja) | 2019-10-16 | 2025-12-24 | 高親油性生理活性物質の放出制御製剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240148758A1 (https=) |
| EP (2) | EP3808336A1 (https=) |
| JP (2) | JP7850068B2 (https=) |
| CN (1) | CN114929197A (https=) |
| AU (1) | AU2020366134B2 (https=) |
| BR (1) | BR112022006678A2 (https=) |
| CA (1) | CA3157693A1 (https=) |
| IL (1) | IL292019A (https=) |
| MX (1) | MX2022004522A (https=) |
| WO (1) | WO2021074399A1 (https=) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4415547A (en) * | 1982-06-14 | 1983-11-15 | Sterling Drug Inc. | Sustained-release pharmaceutical tablet and process for preparation thereof |
| SK287111B6 (sk) * | 1998-08-27 | 2009-12-07 | Pharmacia & Upjohn Ab | Farmaceutický prípravok obsahujúci tolterodin s regulovaným uvoľňovaním |
| DE10226494A1 (de) * | 2002-06-14 | 2004-01-08 | Lts Lohmann Therapie-Systeme Ag | Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen |
| WO2008021394A2 (en) * | 2006-08-15 | 2008-02-21 | Theraquest Biosciences, Llc | Pharmaceutical formulations of cannabinoids and method of use |
| WO2008024490A2 (en) | 2006-08-24 | 2008-02-28 | Theraquest Biosciences, Inc. | Oral pharmaceutical formulations of abuse deterrent cannabinoids and method of use |
| US20130338220A1 (en) * | 2010-10-05 | 2013-12-19 | Mark Tepper | Compositions, dosages, and methods of using tetrahydrocannabinol derivatives |
| AU2014340709B2 (en) | 2013-10-29 | 2019-07-04 | Echo Pharmaceuticals B.V. | Compressed tablet containing cannabidiol, method for its manufacture and use of such tablet in oral treatment of psychosis or anxiety disorders |
| WO2018035030A1 (en) | 2016-08-15 | 2018-02-22 | Corr-Jensen Inc. | Time release fat-soluble actives |
| EP3808341A1 (de) * | 2019-10-16 | 2021-04-21 | ADD Advanced Drug Delivery Technologies, Ltd. | Kontrolliert freisetzende formulierungen stark lipophiler physiologisch aktiver substanzen |
-
2019
- 2019-10-16 EP EP19203549.1A patent/EP3808336A1/de not_active Withdrawn
-
2020
- 2020-10-16 WO PCT/EP2020/079244 patent/WO2021074399A1/de not_active Ceased
- 2020-10-16 CN CN202080072481.0A patent/CN114929197A/zh active Pending
- 2020-10-16 MX MX2022004522A patent/MX2022004522A/es unknown
- 2020-10-16 JP JP2022521680A patent/JP7850068B2/ja active Active
- 2020-10-16 IL IL292019A patent/IL292019A/en unknown
- 2020-10-16 US US17/769,398 patent/US20240148758A1/en active Pending
- 2020-10-16 AU AU2020366134A patent/AU2020366134B2/en active Active
- 2020-10-16 BR BR112022006678A patent/BR112022006678A2/pt unknown
- 2020-10-16 CA CA3157693A patent/CA3157693A1/en active Pending
- 2020-10-16 EP EP20800799.7A patent/EP4045007A1/de active Pending
-
2025
- 2025-12-24 JP JP2025279962A patent/JP2026034780A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2310147C (fr) | Spheroides, procede de preparation et compositions pharmaceutiques | |
| Zaghloul et al. | Rutin and selenium nanoparticles protected against STZ-induced diabetic nephropathy in rats through downregulating Jak-2/Stat3 pathway and upregulating Nrf-2/HO-1 pathway | |
| EE03471B1 (et) | Dopamiini agonisti sisaldav farmatseutiline kompositsioon, selle kasutamine ja valmistamismeetod, farmatseutiline produkt ja komplekt ning antatsiidi kasutamine | |
| FR2761266A1 (fr) | Composition pharmaceutique formee par granulation humide pour l'administration orale d'un derive du n-piperidino-3- pyrazolecarboxamide, de ses sels et de leurs solvates | |
| FR2631233A1 (fr) | Comprime de chlorhydrate de ranitidine enrobe | |
| JPS58403B2 (ja) | Ｌ− アスコルビンサンセイザイノ セイゾウホウ | |
| JP2025182116A5 (https=) | ||
| WO2007102242A1 (ja) | 外用の医薬組成物 | |
| JP2025182116A (ja) | 高親油性生理活性物質の放出制御製剤 | |
| EP1178778A2 (fr) | Granules contenant une substance vegetale et leur procede de preparation | |
| CN104870544B (zh) | 用于形成复合物的组合物、由此形成的复合物和用于口服的含所述复合物的组合物 | |
| JPWO2021074399A5 (https=) | ||
| JPWO2021074403A5 (https=) | ||
| JP6308137B2 (ja) | 皮膚適用製剤 | |
| JP2009501214A (ja) | クロピドグレルビスルファートを含有する薬学的組成物 | |
| FR2705895A1 (fr) | Comprimés médicamenteux exempts d'agent lubrifiant. | |
| EA015440B1 (ru) | Твердая лекарственная форма, содержащая полиморфную форму 1 клопидогрела гидросульфата | |
| JP2025510868A (ja) | ミラベグロン製剤 | |
| JP7850068B2 (ja) | 高親油性生理活性物質の放出制御製剤 | |
| CN105147636A (zh) | 瑞舒伐他汀钙胶囊及其制备方法 | |
| FR3031678B1 (fr) | Utilisation conjointe de asp-8adt et d'un inhibiteur d'autophagie dans le traitement de cancer. | |
| JP2017506647A (ja) | 爪真菌症を治療するための局所用抗真菌薬組成物 | |
| Al-Pokhiti et al. | Development and evaluation of sustained release matrix tablets of ketoprofen employing natural polymers (pomegranate peel and acacia powders) | |
| TWI292315B (en) | Composition for decreasing lipids in blood | |
| KR100591786B1 (ko) | 프란루카스트를 함유하는 약학적 조성물 및 이의 제조 방법 |